PROGRAM AGENDA
The objective of the Update on Clinical Topics in Antiretroviral Therapy workshop is to update and review the latest practices in the field of antiretroviral treatment from a theoretical, practical and interactive perspective and it is aimed at an audience of HIV and infectious diseases healthcare professionals and researchers.
| Friday 27th April 2018 | |||
| 14.30-15:30 | Registration and lunch | Organizing committee | |
| 15:30- 15.45 | Welcome | B. Clotet | |
| Block 1. Initial Antiretroviral Therapy | Chair: J. M Llibre | ||
| 15.45-16.15 | Initial ART, always integrase inhibitors? | C. Orkin | |
| 16.15-16.45 | Relevant drug interactions in 2018 – Impact on ART choice | J. Moltó | |
| 16.45–17.15 | Management of patients with low-level viremia | Marije Hofstra | |
| 17.15-17.45 | Overall discussion | ||
| 17.45- 18.15 | Coffee break | ||
| 18.15–19.00 | Clinical cases discussion – Break-out session | Franco Maggiolo
Adrià Curran Arkaitz Imaz Jose Ignacio Bernardino |
|
| 19.00- 20.30 | Cocktail Reception | ||
| Saturday 28th April 2018 | ||||
| Block 2. Switching Antiretroviral Therapy | Chair: Franco Maggiolo | |||
| 9.00- 9.30 | Strategies to use | Hans-Jürgen Stellbrink | ||
| 9.30-10.00 | Dual ART | JM .Llibre | ||
| 10.00–10.30 | Long-acting formulations | C. Flexner | ||
| 10.30-11.00 | Implications from the virology field in successful ART | C. F. Perno | ||
| 11.00-11.30 | Overall discussion | |||
| 11.30–12.00 | Coffee break | |||
| Block 3. ART Guidelines | Chair: J. Schapiro | |||
| 12.00-12.30 | When early is not early enough : same day ART – late presenters | Benjamin Young | ||
| 12.30-13.00 | Review/comparison current guidelines for ART management | JM. Gatell | ||
| 13.00-13.30 | Clinical impact: Novel WHO and IAS-USA HIV resistance guidelines | R. Paredes | ||
| 13.30–14.00 | Overall discussion | |||
| 14.00- 14.15 | Closing remarks | B. Clotet | ||
| 14.15 – 15.00 | Lunch | |||